Karen Burns

5.7k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

Karen Burns is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Karen Burns has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Infectious Diseases and 14 papers in Molecular Medicine. Recurrent topics in Karen Burns's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotic Use and Resistance (11 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Karen Burns is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotic Use and Resistance (11 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Karen Burns collaborates with scholars based in Ireland, United Kingdom and United States. Karen Burns's co-authors include Fidelma Fitzpatrick, Mark H. Wilcox, Robin M. Overstreet, Ed J. Kuijper, Nancy J. Brown‐Peterson, Bente Olesen, Marcela Krůtová, Maria J. G. T. Vehreschild, Joffrey van Prehn and John Coia and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Pharmacology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Karen Burns

52 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

2021 354 citations Joffrey van Prehn, Elena Reigadas et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Karen Burns

Since Specialization

Citations

This map shows the geographic impact of Karen Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Burns more than expected).

Fields of papers citing papers by Karen Burns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Burns. The network helps show where Karen Burns may publish in the future.

Co-authorship network of co-authors of Karen Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Burns. A scholar is included among the top collaborators of Karen Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Burns. Karen Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Read Sequencing for the Rapid Response to Infectious Diseases Outbreaks 2025 ·Current Clinical Microbiology Reports ·(unknown), Karen Burns, Jeffrey Warner, Ulf Schmitz	5
2	Antimicrobial prescribing in acute pancreatitis: Too much for too many? 2024 ·Clinical Infection in Practice ·(unknown), (unknown), (unknown), (unknown), Karen Burns, (unknown), S. O’Donnell, (unknown), (unknown), (unknown), Fidelma Fitzpatrick, Christopher M. O’Connor	1
3	Getting to the heart of the matter—are two agents really better than one for the treatment of staphylococcal infective endocarditis? 2024 ·International Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Christopher M. O’Connor, (unknown), S. O’Donnell, (unknown), Karen Burns, Fidelma Fitzpatrick	0
4	European Practice for CDI Treatment 2024 ·Advances in experimental medicine and biology ·Fidelma Fitzpatrick, (unknown), Joffrey van Prehn, Máiréad Skally, Melissa Brady, Karen Burns, Christopher Rooney, Mark H. Wilcox	2
5	Social network and genomic analysis of an OXA-48 carbapenemase-producing Enterobacterales hospital ward outbreak in Ireland, 2018–2019 2023 ·Infection Prevention in Practice ·Lisa Domegan, Carina Brehony, Fidelma Fitzpatrick, (unknown), (unknown), (unknown), Karen Burns	1
6	Reflections on a national public health emergency response to carbapenemase-producing Enterobacterale 2022 ·Research Portal (Queen's University Belfast) ·H. Humphreys, Martin Cormican, (unknown), Karen Burns, Diarmuid O’Donovan, (unknown), (unknown), (unknown)	5
7	Multidisciplinary neurosurgical rounds incorporating antimicrobial stewardship. Are they of benefit? 2022 ·SHILAP Revista de lepidopterología ·(unknown), H. Humphreys, Roisín M. Connolly, (unknown), Máiréad Skally, John Caird, John C. Duddy, Philip J. O’Halloran, (unknown), Karen Burns, (unknown), E.G. Smyth, Karen J. O’Connell, Fidelma Fitzpatrick	2
8	European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults breakdown → 2021 ·Clinical Microbiology and Infection ·Joffrey van Prehn, Elena Reigadas, Erik Vogelzang, Emilio Bouza, Adriana Hristea, Benoît Guéry, Marcela Krůtová, Torbjörn Norén, Franz Allerberger, John Coia, Abraham Goorhuis, Tessel M. van Rossen, Rogier E. Ooijevaar, Karen Burns, Bente Olesen, Sarah Tschudin‐Sutter, Mark H. Wilcox, Maria J. G. T. Vehreschild, Fidelma Fitzpatrick, Ed J. Kuijper	354
9	The other ‘C’: Hospital-acquired Clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic 2021 ·Infection Control and Hospital Epidemiology ·(unknown), Máiréad Skally, (unknown), Margaret Foley, Karen Burns, Aoibhlinn O’Toole, Karen Boland, Fidelma Fitzpatrick	20
10	Initial impact of a national programme to contain the spread of carbapenemase-producing Enterobacterales in Ireland 2021 ·Journal of Hospital Infection ·Akke Vellinga, (unknown), H. Humphreys, Karen Burns	12
11	Evolving epidemiology of carbapenemase-producing Enterobacterales: one hospital's infection prevention and control response over nine years 2021 ·Journal of Hospital Infection ·(unknown), (unknown), Máiréad Skally, (unknown), (unknown), M. O'Connor, (unknown), (unknown), Karen Burns, Fidelma Fitzpatrick, (unknown), E.G. Smyth, H. Humphreys	11
12	Molecular epidemiology of an extended multiple-species OXA-48 CPE outbreak in a hospital ward in Ireland, 2018–2019 2021 ·SHILAP Revista de lepidopterología ·Carina Brehony, Lisa Domegan, Margaret Foley, Margaret A. Fitzpatrick, (unknown), (unknown), (unknown), Eleanor McNamara, (unknown), Fidelma Fitzpatrick, Karen Burns	7
13	Bluetongue Disease Control in Northern Ireland During 2017 and 2018 2019 ·Frontiers in Veterinary Science ·(unknown), A. K. Murchie, (unknown), David F. Mercer, Sarah Millington, William P. Thurston, Karen Burns, (unknown), (unknown), F. D. Menzies	0
14	European Practice for CDI Treatment 2018 ·Advances in experimental medicine and biology ·Fidelma Fitzpatrick, Máiréad Skally, Melissa Brady, Karen Burns, Christopher Rooney, Mark H. Wilcox	9
15	Food for thought. Malnutrition risk associated with increased risk of healthcare-associated infection 2018 ·Journal of Hospital Infection ·Fidelma Fitzpatrick, Máiréad Skally, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), E.G. Smyth, H. Humphreys, Karen Burns	13
16	Point prevalence survey of healthcare-associated infections and use of antimicrobials in Irish intellectual disability long-term care facilities: 2013 2016 ·Journal of Hospital Infection ·Fiona Roche, (unknown), Karen Burns	8
17	What may be lurking in the hospital undergrowth? Inapparent cross-transmission of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 2014 ·Journal of Hospital Infection ·Máiréad Skally, (unknown), Karen Burns, Diana Doyle, Susan Foley, (unknown), C. B. Collins, E.G. Smyth, Jane F. Turton, H. Humphreys	4
18	Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland 2010 ·Journal of Hospital Infection ·Karen Burns, M. Morris-Downes, Warren N. Fawley, E.G. Smyth, Mark H. Wilcox, Fidelma Fitzpatrick	25
19	Clostridium difficileInfection in the Republic of Ireland: Results of a 1-Month National Surveillance and Ribotyping Project, March 2009 2010 ·Infection Control and Hospital Epidemiology ·Karen Burns, Máiréad Skally, Katie Solomon, (unknown), (unknown), D O’Flanagan, Séamus Fanning, Lorraine Kyne, Lynda Fenelon, Fidelma Fitzpatrick	7
20	Reproductive Biology of Cobia, Rachycentron canadum, from Coastal Waters of the Southern United States 2001 ·Fishery Bulletin ·Nancy J. Brown‐Peterson, Robin M. Overstreet, Jeffrey M. Lotz, James S. Franks, Karen Burns	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact